Anti-colon antibody and lymphocytophilic antibody in ulcerative colitis

T. Hibi, Sadakazu Aiso, T. Yoshida, M. Watanabe, H. Asakura, S. Tsuru, M. Tsuchiya

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The presence of anti-colon antibody in the sera from patients with ulcerative colitis was demonstrated by antibody-dependent cell-mediated cytotoxicity (ADCC) assay. In addition, the high prevalence of lymphocytophilic antibody in the sera from patients with ulcerative colitis was obtained by fluorescence activated cell sorter (FACS) analysis. This lymphocytophilic antibody was absorbed by rat colon epithelial cells. Moreover the lymphocytes from ulcerative colitis showed lower binding capacity to this antibody, but acquired higher binding capacity after 20 hr incubation at 37°C in vitro. These data suggest that ADCC may have some role in the pathogenesis of ulcerative colitis.

Original languageEnglish
Pages (from-to)75-80
Number of pages6
JournalClinical and Experimental Immunology
Volume49
Issue number1
Publication statusPublished - 1982 Sep 20
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Hibi, T., Aiso, S., Yoshida, T., Watanabe, M., Asakura, H., Tsuru, S., & Tsuchiya, M. (1982). Anti-colon antibody and lymphocytophilic antibody in ulcerative colitis. Clinical and Experimental Immunology, 49(1), 75-80.

Anti-colon antibody and lymphocytophilic antibody in ulcerative colitis. / Hibi, T.; Aiso, Sadakazu; Yoshida, T.; Watanabe, M.; Asakura, H.; Tsuru, S.; Tsuchiya, M.

In: Clinical and Experimental Immunology, Vol. 49, No. 1, 20.09.1982, p. 75-80.

Research output: Contribution to journalArticle

Hibi, T, Aiso, S, Yoshida, T, Watanabe, M, Asakura, H, Tsuru, S & Tsuchiya, M 1982, 'Anti-colon antibody and lymphocytophilic antibody in ulcerative colitis', Clinical and Experimental Immunology, vol. 49, no. 1, pp. 75-80.
Hibi T, Aiso S, Yoshida T, Watanabe M, Asakura H, Tsuru S et al. Anti-colon antibody and lymphocytophilic antibody in ulcerative colitis. Clinical and Experimental Immunology. 1982 Sep 20;49(1):75-80.
Hibi, T. ; Aiso, Sadakazu ; Yoshida, T. ; Watanabe, M. ; Asakura, H. ; Tsuru, S. ; Tsuchiya, M. / Anti-colon antibody and lymphocytophilic antibody in ulcerative colitis. In: Clinical and Experimental Immunology. 1982 ; Vol. 49, No. 1. pp. 75-80.
@article{50d54785b95f4a3b847ac5490f258f7c,
title = "Anti-colon antibody and lymphocytophilic antibody in ulcerative colitis",
abstract = "The presence of anti-colon antibody in the sera from patients with ulcerative colitis was demonstrated by antibody-dependent cell-mediated cytotoxicity (ADCC) assay. In addition, the high prevalence of lymphocytophilic antibody in the sera from patients with ulcerative colitis was obtained by fluorescence activated cell sorter (FACS) analysis. This lymphocytophilic antibody was absorbed by rat colon epithelial cells. Moreover the lymphocytes from ulcerative colitis showed lower binding capacity to this antibody, but acquired higher binding capacity after 20 hr incubation at 37°C in vitro. These data suggest that ADCC may have some role in the pathogenesis of ulcerative colitis.",
author = "T. Hibi and Sadakazu Aiso and T. Yoshida and M. Watanabe and H. Asakura and S. Tsuru and M. Tsuchiya",
year = "1982",
month = "9",
day = "20",
language = "English",
volume = "49",
pages = "75--80",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Anti-colon antibody and lymphocytophilic antibody in ulcerative colitis

AU - Hibi, T.

AU - Aiso, Sadakazu

AU - Yoshida, T.

AU - Watanabe, M.

AU - Asakura, H.

AU - Tsuru, S.

AU - Tsuchiya, M.

PY - 1982/9/20

Y1 - 1982/9/20

N2 - The presence of anti-colon antibody in the sera from patients with ulcerative colitis was demonstrated by antibody-dependent cell-mediated cytotoxicity (ADCC) assay. In addition, the high prevalence of lymphocytophilic antibody in the sera from patients with ulcerative colitis was obtained by fluorescence activated cell sorter (FACS) analysis. This lymphocytophilic antibody was absorbed by rat colon epithelial cells. Moreover the lymphocytes from ulcerative colitis showed lower binding capacity to this antibody, but acquired higher binding capacity after 20 hr incubation at 37°C in vitro. These data suggest that ADCC may have some role in the pathogenesis of ulcerative colitis.

AB - The presence of anti-colon antibody in the sera from patients with ulcerative colitis was demonstrated by antibody-dependent cell-mediated cytotoxicity (ADCC) assay. In addition, the high prevalence of lymphocytophilic antibody in the sera from patients with ulcerative colitis was obtained by fluorescence activated cell sorter (FACS) analysis. This lymphocytophilic antibody was absorbed by rat colon epithelial cells. Moreover the lymphocytes from ulcerative colitis showed lower binding capacity to this antibody, but acquired higher binding capacity after 20 hr incubation at 37°C in vitro. These data suggest that ADCC may have some role in the pathogenesis of ulcerative colitis.

UR - http://www.scopus.com/inward/record.url?scp=0019996065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019996065&partnerID=8YFLogxK

M3 - Article

C2 - 7127904

AN - SCOPUS:0019996065

VL - 49

SP - 75

EP - 80

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 1

ER -